|
3.111
Adult (³age
18).
3.112
Histological or cytological proven cancer other than brain,
breast, ovarian, or endometrial cancer. If the patient has
multiple primaries or an unknown primary, the currently
active cancer cannot be known to be of brain, breast, ovarian,
or endometrial cancer.
3.113
Patient life expectancy ³3
months.
3.114
ECOG performance score 0, 1, or 2.
3.115
Able to reliably take oral medication.
3.116
Alert and mentally competent.
3.117
Patients must have a history of having lost at least five
pounds (2.3 kg) in weight over the preceding two months
or less (excluding perioperative weight loss; documented
weight loss not required) and/or have estimated caloric
intake of <20 cal/kg daily.
3.118
The attending physician must determine that weight gain
would be beneficial to the patient.
3.119a
Patient perceives weight loss as a problem.
3.119b
Concurrent chemotherapy and/or radiotherapy is permitted.
3.119c
All patients should be considered incurable with available
therapies.
3.12
Contraindications.
3.121
Receiving tube feedings or parenteral nutrition.
3.122
Evidence of ascites.
3.123
Current (within the past month) or planned treatment with
adrenal steroids (short-term use of dexamethasone around
days of intravenous chemotherapy is allowed for protection
against emesis), androgens, progestational agents, or
appetite stimulants (e.g. dronabinol).
|